Moderna to Collaborate with Harvard on mRNA Immunotherapy
- Posted by ISPE Boston
- On October 3, 2019
Cambridge-based, clinical-stage biotech Moderna has announced a multi-year research collaboration with Harvard University to identify and develop novel therapeutic approaches that could improve the lives of patients with immunological diseases. Additional funding from Moderna to Harvard Medical School (HMS) will establish an initiative at HMS called the Alliance for RNA Therapies for the Modulation of […]
Read More